Skip to main content
SpringerLink
Log in

In vivo labelling of pituitary dopamine D-2 receptors in the male rat using [3H]-raclopride

  • Original Papers
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

The substituted benzamide drug [3H]-raclopride (Köhler et al., 1985) was used to label dopamine D-2 receptors within the individual lobes of the pituitary gland as well as in the brain of male rats in vivo. The in vivo [3H]-raclopride binding was found to be saturable, reversible and of high specificity. Between 5–30% of the binding was non-specific at saturating concentrations dependent upon the lobe of the pituitary gland as well as of the brain region (e.g., caudate nucleus and olfactory tubercle) studied. Saturation analyses revealed Bmax-values of 12.9±1.6 and 2.2±0.9pmol·g−1 wet weight in the intermediate and anterior lobes, respectively with respective KD values of 6.5±4.6 and 7.3±2.4 nmol·kg−1. Quantitative autoradiographic studies using a single concentration of [3H]-raclopride showed a similar relationship with regard to binding densities in the different lobes, and showed, in addition, that the posterior lobe contained the lowest number of specific [3H]-raclopride binding sites. The binding capacities and affinities of binding were 12.9±1.7 and 9.2±2.8 respectively in the caudate nucleus and 6.1±0.7 and 9.3±2.7 respectively in the olfactory tubercle.

The pharmacological analysis revealed that (S)sulpiride, remoxipride and raclopride were 10 to 125 times more potent than their corresponding isomers [(R)sulpridie, FLA 731(−), and FLB 472, respectively] in blocking the in vivo [3H]raclopride binding in the pituitary gland as well as in brain. The in vivo potency of different D-2 antagonists in preventing the [3H]-raclopride binding in the anterior and intermediate lobes was: spiperone > domperidone > raclopride > (S)sulpiride > remoxipride. The D-1 selective antagonist SCH 23390 did not block the in vivo binding of [3H]-raclopride neither in the pituitary lobes nor in the brain. In agreement with these findings the D-2 agonists N,N-propylnorapomorphine and quinpirole (LY 171555) but not the D-1 agonist SKF 38393-A blocked the specific in vivo [3H]-raclopride binding in the pituitary gland as well as in the brain. Comparisons between the relative potencies of different drugs in blocking pituitary and brain D-2 receptors in vivo showed that some drugs, including sulpiride and domperidone, were more potent in the pituitary gland than in the brain, while remoxipride and raclopride were equipotent in the two areas. The D-2 agonists tested appeared to be slightly more potent in the brain than in the pituitary gland.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anderson PH, Grünvald FG (1986) Specific binding of [3H]-SCH 23390 to dopamine D-1 receptors in vivo. Life Sci 38: 1507–1514

    Google Scholar 

  • Apud JA, Masotto C, Origini E, Racagni G (1985) Interaction of SCH 23390, a D-1 selective antagonist with the anterior pituitary D-2 receptor and prolactin secretion in the rat. Eur J Pharmacol 112: 187–193

    Google Scholar 

  • Baudry M, Martres MP, Schwartz JC (1979) [3H]-domperidone: a selective ligand for dopamine receptors. Naunyn Schmiedebergs Arch Pharmacol 308: 231–237

    Google Scholar 

  • Beaulieu M, Felder B, Kebabian JW (1986) D-2 dopaminergic agonist and adenosine 3′,5′-monophosphate directly regulate the synthesis of α-melanocyte-stimulating hormone-like peptide by cultured rat melanotrops. Endocrinology 118: 1032–1039

    Google Scholar 

  • Ben-Jonathan N (1985) Dopamine: a prolactin-inhibiting hormone. Endocr Rev 6: 564–589

    Google Scholar 

  • Besser GM, Delitala G, Grossman A, Stubbs WA, Yeo T (1980) Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations. Br J Pharmacol 71: 569–573

    Google Scholar 

  • Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A (1984) Characterization of the binding of [3H]-SCH 23390, a selective D-1 receptor antagonist ligand in rat striatum. Life Sci 35: 1885–1893

    Google Scholar 

  • Bischoff S, Bittiger H, Delini-Stula A, Ortmann R (1982) Septo-hippocampal system: target for substituted benzamides. Eur J Pharmacol 79: 225–232

    Google Scholar 

  • Borgundvaag B, George SR (1985) Dopamine inhibition of anterior pituitary adenylate cyclase is mediated through the high affinity state of the D-2 receptor. Life Sci 37: 379–386

    Google Scholar 

  • Brown GM, Seeman P, Lee T (1976) Dopamine/neuroleptic receptors in basal hypothalamus and pituitary. Endocrinology 99: 1407–1410

    Google Scholar 

  • Caron MG, Beaulieu M, Raymond V, Gagné B, Drouin J, Lefkowitz RJ, Labrie F (1978) Dopamine receptors in the anterior pituitary gland. Correlation of [3H]-dihydroergocryptine binding with the dopaminergic control of prolactin release. J Biochem Chem 253: 2244–2253

    Google Scholar 

  • Cote TE, Grewe CW, Kebabian JW (1981) Stimulation of a D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland decreases the responsiveness of the Β-adrenoceptor: biochemical mechanism. Endocrinology 108: 420–426

    Google Scholar 

  • Creese I, Schneider R, Snyder SH (1977) [3H]-spiroperidol labels dopamine receptors in pituitary and brain. Eur J Pharmacol 46: 377–381

    Google Scholar 

  • Cronin MJ, Roberts JM, Weiner RI (1978) Dopamine and dihydroergocryptine binding to the anterior pituitary and other brain areas of the rat and sheep. Endocrinology 103: 302–309

    Google Scholar 

  • Cronin MJ, Weiner RI (1979) [3H]Spiroperidol (spiperone) binding to a putative dopamine receptor in sheep and steer pituitary and stalk median eminence. Endocrinology 104: 307–312

    Google Scholar 

  • De Lean A, Kilpatrick BF, Caron MG (1982) Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists. Mol Pharmacol 22: 290–297

    Google Scholar 

  • De Souza EB, Kuhar MJ (1984) Dopamine receptors in the anterior lobe of the human pituitary gland: autoradiographic localization. Brain Res 306: 391–395

    Google Scholar 

  • Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström C-G, Litton JE, Sedvall G (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82: 3863–3867

    Google Scholar 

  • George SR, Kertsz M (1985) Dopamine receptors regulate Met-enkephalin content in pituitary. Brain Res 334: 187–189

    Google Scholar 

  • George SR, Watanabe M, Seeman P (1985) Dopamine D-2 receptors in brain and anterior pituitary recognize agonist and antagonist actions of (−)-3-PPP. J Neural Transm 64: 73–133

    Google Scholar 

  • Hall H, Wedel I (1986) Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine D-2 receptors in the rat striatum. Arch Pharmacol Toxicol 58: 368–373

    Google Scholar 

  • Hall MD, Jenner P, Marsden CD (1983) Differential labelling of dopamine receptors in the rat brain in vivo: comparison of [3H]-piribedil, [3H]-S 3608 and [3H]-N,N-propylnorapomorphine. Eur J Pharmacol 87: 85–94

    Google Scholar 

  • Horowski R, GrÄf K-J (1976) Influence of dopaminergic agonist and antagonists on serum prolactin concentrations in the rat. Neuroendocrinology 22: 273–286

    Google Scholar 

  • Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93–96

    Google Scholar 

  • Köhler Ch, Fahlberg K (1985) Specific in vivo binding of [3H]-spiperone to individual lobes of the pituitary gland of the rat. Evidence for the labelling of dopamine receptors. J Neural Transm 63: 39–52

    Google Scholar 

  • Köhler Ch, Karlsson-Boethius G (1988) In vivo labelling of rat dopamine D-2 receptors. Stereoselective blockade by the D-2 antagonist raclopride and its enantiomer of3H-spiperone,3H-N,N-propylnorapomorphine and3H-raclopride binding in the rat brain. J Neural Transm 73: 87–100

    Google Scholar 

  • Köhler Ch, ögren S-O, Haglund L, Ängeby T (1979) Regional displacement by sulpiride of [3H]-spiperone binding in vivo. Biochemical and behavioral evidence for a preferential action on limbic and nigral dopamine receptors. Neurosci Lett 13: 51–56

    Google Scholar 

  • Köhler Ch, Haglund L, ögren S-O, Ängeby T (1981) Regional blockade by neuroleptic drugs of in vivo [3H]-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies. J Neural Transm 52: 163–173

    Google Scholar 

  • Köhler Ch, Fuxe K, Ross S (1984a) Regional in vivo binding of [3H]-N-propylnorapomorphine in the mouse brain: evidence for labelling of central dopamine receptors. Europ J Pharmacol 72: 125–138

    Google Scholar 

  • Köhler Ch, ögren S-O, Fuxe K (1984b) Studies on the mechanism of action of substituted benzamide drugs. Acta Physiol Scand 69: 125–138

    Google Scholar 

  • Köhler Ch, Hall H, ögren S-O, Gawell L (1985) Specific in vitro and in vivo binding of [3H]-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol 34: 2251–2259

    Google Scholar 

  • Köhler Ch, Hall H, Gawell L (1986) Regional in vivo binding of the substituted benzamide [3H]-eticlopride in the rat brain; evidence for selective labelling of dopamine receptors. Eur J Pharmacol 120: 217–226

    Google Scholar 

  • Kuhar MJ, Murrin CL, Malouf AT, Klemm N (1978) Dopamine receptor binding in vivo, the feasibility of autoradiographic studies. Life Sci 22: 203–210

    Google Scholar 

  • Laduron P, Leysen J (1977) Specific in vivo binding of neuroleptic drugs in rat brain. Biochem Pharmacol 26: 103–1007

    Google Scholar 

  • Leysen J, Gommeren W, Laduron PM (1978) Spiperone: a ligand of choice for neuroleptic receptors. I. Kinetics and characteristics of in vitro binding. Biochem Pharmacol 27: 307–316

    Google Scholar 

  • Lightman SL, Ninkovic M, Hunt SP (1982) Localization of [3H]-spiperone binding sites in the intermediate lobe of the rat pituitary gland. Neurosci Lett 32: 99–102

    Google Scholar 

  • Meltzer HY, So R, Miller RJ, Fang VS (1979) Comparison of the effects of substituted and standard neuroleptics on the binding of [3H]-spiroperidol in the rat pituitary and striatum with “in vivo” effects of rat prolactin secretion. Life Sci 25: 573–584

    Google Scholar 

  • Meites J, Sonntag WE (1981) Hypothalamic hypophysiotropic hormones and neurotransmitter regulation: current views. Ann Rev Pharmacol Toxicol 21: 295–322

    Google Scholar 

  • Munemura M, Cote TE, Tsuruta K, Eskay RL, Kebabian JW (1980) The dopamine receptor in the intermediate lobe of the pituitary gland; pharmacological characterization. Endocrinology 107: 1676–1683

    Google Scholar 

  • O'Boyle KM, Waddington JL (1984) Selective and stereospecific interactions of R SKF 38392 with [3H]-piflutixol but not [3H]-spiperone binding to striatal D-1 and D-2 dopamine receptors: Comparism with SCH 23390: Eur J Pharmacol 98: 433–437

    Google Scholar 

  • ögren S-O, Hall H, Köhler Ch, Magnusson O, Lindbom L-O, Ängeby K, Florvall (1984) Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brain. Eur J Pharmacol 102: 459–474

    Google Scholar 

  • ögren S-O, Hall H, Köhler Ch, Magnusson O, Sjöstrand SE (1986) The selective dopamine D-2-receptor antagonist raclopride discriminates between dopamine mediated functions. Psychopharmacology 90: 287–294

    Google Scholar 

  • Pazos A, Stoeckel ME, Hindelaug C, Palacios JM (1985) Autoradiographic studies on dopamine D-2 receptors in rat pituitary: influence of hormonal states. Neurosci Lett 59: 1–7

    Google Scholar 

  • Seeman P (1986) Brain dopamine receptors. Pharmacol Rev 32: 229–313

    Google Scholar 

  • Sokoloff P, Martres M-P, Delandre M, Redouane K, Schwartz JC (1984) [3H]-domperidone binding sites differ in rat striatum and pituitary. Naunyn Schmiedebergs Arch Pharmacol 327: 221–227

    Google Scholar 

  • Stefanini E, Devotok P, Marchisio AM, Varnaleone F, Collu R (1980) [3H]-Spiperone binding to a pitutive dopaminergic receptor in rat pituitary gland. Life Sci 26: 538–587

    Google Scholar 

  • Stoof JC, Kebabian JW (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35: 2281–2296

    Google Scholar 

  • Theodorou A, Crocket M, Jenner P, Marsden CD (1979) Specific binding of [3H]-Sulpiride to rat striatal preparations. J Pharmacol 31: 424–426

    Google Scholar 

  • Unnerstall JR, Niehoff DL, Kuhar MJ, Palacios JM (1982) Quantitative receptor autoradiography using [3H]Ultrofilm: application to multiple benzodiazepine receptors. J Neurosci Methods 6: 59–73

    Google Scholar 

  • Yeo T, Thorner MO, Jones A, Lowry PJ, Beser GM (1979) The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuous perfused columns of isolated rat pituitary cells. J Clin Endocrinol 10: 123–133

    Google Scholar 

  • Van der Werf JF, Sebens JB, Korf J (1986) Tracer and maximal specific binding of tritiated spiperone or N,N-propylnorapomorphine to quantify dopamine receptors in rat brain in vivo. Life Sci 39: 155–160

    Google Scholar 

  • Wagner HN, Burns HD, Dannais RF, Wong DF, Långström B, Duelfer T, Frost JJ, Ravert HT, Links JM, Rosenbloom SV, Lukas SE, Kramer AV, Kuhar MJ (1983) Imaging dopamine receptors in the human brain by positron tomography. Science 221: 1264–1266

    Google Scholar 

Download references

Author information

Author notes

  1. Ch. Köhler

    Present address: Department of Neuropharmacology, Astra Alab AB, SödertÄlje, Sweden

Authors and Affiliations

  1. Department of Neuropharmacology, Astra Alab AB, SödertÄlje, Sweden

    G. Karlsson-Boethius

Authors
  1. Ch. Köhler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Karlsson-Boethius
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Köhler, C., Karlsson-Boethius, G. In vivo labelling of pituitary dopamine D-2 receptors in the male rat using [3H]-raclopride. J. Neural Transmission 76, 13–28 (1989). https://doi.org/10.1007/BF01244988

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01244988

Keywords

Search

Navigation